Ignite Creation Date:
2024-05-05 @ 4:48 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00315731
Status:
COMPLETED
Last Update Posted:
2017-07-11
First Post:
2006-04-17
Brief Title:
A Study Of Pharmacokinetics Whole Body And Organ Dosimetry And Biodistribution Of Fission-Derived Iodine I 131 Tositumomab BEXXAR For Patients With Previously Untreated Or Relapsed Follicular Or Transformed Non-Hodgkins Lymphoma
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-03-31
Start Date Type:
ACTUAL
Primary Completion Date:
2006-12-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-06-30
Completion Date Type:
ACTUAL
First Submit Date:
2006-04-17
First Submit QC Date:
April 17 2006
Study First Post Date:
2006-04-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2012-04-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-09
Last Update Post Date:
2017-07-11
Last Update Post Date Type:
ACTUAL